🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase 1, open-label, dose escalation study in patients with advan...
Status
Completed
Location
Next Oncology
Start Date
2020-09-23
Trial ID
NCT04501276
Treatments Being Tested
Subjects on this study have a type of lymph gland cancer called Non-Hodgkin...
Status
Recruiting
Location
Houston Methodist Hospital
Start Date
2014-02
Trial ID
NCT01853631
This is a Phase 1/1b, multicenter, open label study to evaluate the Safety ...
Status
Active Not Recruiting
Location
Yale University
Start Date
2020-11-18
Trial ID
NCT04648202
Treatments Being Tested
The goal of this observational study is to explore whether changes in perip...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-04
Trial ID
NCT07392073
Treatments Being Tested
This is a phase IB/II, open-label study evaluating CTX-009 as monotherapy a...
Status
Recruiting
Location
Washington University School of Medicine
Start Date
2026-06-16
Trial ID
NCT07392957
The purpose of this study is to determine if BMS-663513 administered in com...
Status
Withdrawn
Location
Local Institution
Start Date
2010-11
Trial ID
NCT00803374
The purpose of this Pilot Study is to investigate the safety, side effects,...
Status
Completed
Location
H. Lee Moffitt Cancer Center and Research Institute
Start Date
2016-03-08
Trial ID
NCT02652455
The study of LVGN6051-201 is designed to use a bridging dose escalation to ...
Status
Completed
Location
Cancer Hospital Chinese Academy of Medical Sciences
Start Date
2021-05-14
Trial ID
NCT04694781
Treatments Being Tested
This platform trial will evaluate various immunotherapy combinations given ...
Status
Active Not Recruiting
Location
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Start Date
2016-03-28
Trial ID
NCT02451982
Treatments Being Tested
The goal of this clinical research study is to learn if utomilumab, when gi...
Status
Terminated
Location
University of Texas MD Anderson Cancer Center
Start Date
2018-04-04
Trial ID
NCT03258008
Treatments Being Tested